BANK OF AMERICA CORP /DE/ - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 75 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 27.90 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q2 2023$33,687
+136.9%
41,588
+104.8%
0.00%
Q1 2023$14,218
-52.5%
20,311
-52.1%
0.00%
Q4 2022$29,931
-3.4%
42,395
+110.7%
0.00%
Q3 2022$31,000
+34.8%
20,122
-13.7%
0.00%
Q2 2022$23,000
-60.3%
23,319
-41.5%
0.00%
Q1 2022$58,000
-79.4%
39,862
-26.2%
0.00%
Q4 2021$282,000
-69.0%
53,991
-65.4%
0.00%
Q3 2021$910,000
-31.5%
156,189
-5.1%
0.00%
Q2 2021$1,328,000
-20.1%
164,665
-17.6%
0.00%
Q1 2021$1,663,000
+48.7%
199,886
+35.5%
0.00%
Q4 2020$1,118,000
-31.0%
147,484
-2.9%
0.00%
Q3 2020$1,620,000
+189.8%
151,917
+312.1%
0.00%
Q2 2020$559,000
+20.0%
36,867
-34.2%
0.00%
Q1 2020$466,000
+4.5%
55,998
+112.5%
0.00%
Q4 2019$446,000
-28.4%
26,352
-21.4%
0.00%
Q3 2019$623,000
-59.2%
33,522
-49.8%
0.00%
Q2 2019$1,527,000
+76.3%
66,716
+62.1%
0.00%
Q1 2019$866,000
+164.8%
41,168
+44.6%
0.00%
Q4 2018$327,000
-41.9%
28,477
+15.9%
0.00%
Q3 2018$563,000
+75.4%
24,570
+71.1%
0.00%
Q2 2018$321,000
-27.7%
14,364
-25.9%
0.00%
Q1 2018$444,000
-17.3%
19,389
-5.3%
0.00%
Q4 2017$537,000
+171.2%
20,477
+132.2%
0.00%
Q3 2017$198,000
-11.6%
8,820
+8.0%
0.00%
Q2 2017$224,000
-39.1%
8,163
-46.3%
0.00%
Q1 2017$368,000
+76.1%
15,200
+51.0%
0.00%
Q4 2016$209,000
-38.7%
10,068
-19.6%
0.00%
Q3 2016$341,000
+72.2%
12,522
-8.9%
0.00%
Q2 2016$198,000
+28.6%
13,746
+28.8%
0.00%
Q1 2016$154,000
-38.6%
10,676
-8.6%
0.00%
Q4 2015$251,000
+151.0%
11,676
+90.0%
0.00%
Q3 2015$100,000
-80.7%
6,144
-69.4%
0.00%
Q2 2015$517,000
+48.1%
20,060
+29.1%
0.00%
Q1 2015$349,000
+30.7%
15,540
+11.8%
0.00%
Q4 2014$267,000
-39.2%
13,899
-32.0%
0.00%
Q3 2014$439,000
-55.0%
20,438
-45.6%
0.00%
Q2 2014$976,000
+1314.5%
37,540
+1085.3%
0.00%
Q1 2014$69,000
-94.8%
3,167
-97.1%
0.00%
Q4 2013$1,321,000
+269.0%
108,242
+305.5%
0.00%
Q3 2013$358,000
+26.1%
26,695
-23.6%
0.00%
Q2 2013$284,00034,9390.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 2,213,326$18,386,00010.92%
ORACLE INVESTMENT MANAGEMENT INC 3,776,121$31,417,0004.70%
GRIFFIN ASSET MANAGEMENT, INC. 1,358,644$11,304,0001.44%
Selkirk Management LLC 288,805$2,403,0000.72%
Chicago Capital, LLC 1,593,126$13,255,0000.56%
Cannell & Co. 1,097,419$9,131,0000.29%
TCI Wealth Advisors, Inc. 55,586$462,0000.20%
Belpointe Asset Management LLC 197,853$1,646,0000.14%
ALGERT GLOBAL LLC 29,580$246,0000.08%
THOMPSON INVESTMENT MANAGEMENT, INC. 60,900$507,0000.08%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders